The current stock price of ROP is 445.11 USD. In the past month the price decreased by -5.19%. In the past year, price decreased by -22.39%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PLTR | PALANTIR TECHNOLOGIES INC-A | 252.5 | 385.00B | ||
| CRM | SALESFORCE INC | 21.76 | 221.22B | ||
| APP | APPLOVIN CORP-CLASS A | 61.8 | 183.75B | ||
| INTU | INTUIT INC | 31.21 | 182.99B | ||
| ADBE | ADOBE INC | 15.84 | 134.31B | ||
| CDNS | CADENCE DESIGN SYS INC | 43.27 | 82.89B | ||
| SNPS | SYNOPSYS INC | 30.01 | 75.20B | ||
| ADSK | AUTODESK INC | 31.59 | 63.05B | ||
| WDAY | WORKDAY INC-CLASS A | 28.52 | 62.82B | ||
| DDOG | DATADOG INC - CLASS A | 81.37 | 55.62B | ||
| MSTR | STRATEGY INC | 3.93 | 50.00B | ||
| FICO | FAIR ISAAC CORP | 59.87 | 42.98B |
Roper Technologies, Inc. is a diversified technology company, which engages in the provision of engineered products and solutions for global niche markets. The company is headquartered in Sarasota, Florida and currently employs 18,200 full-time employees. The company operates businesses that design and develop vertical software and technology-enabled products for a variety of defensible niche markets. The firm operates through three segments: Application Software, Network Software and Technology Enabled Products. The Application Software segment includes Aderant, Clinisys, Data Innovations, Deltek, Frontline, IntelliTrans, PowerPlan, Procare, Strata, Transact/CBORD, and Vertafore. The Network Software segment includes ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, and SoftWriters. The Technology Enabled Products segment includes CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS, and Verathon. Aderant is a comprehensive management software solution for law and other professional services firms. Data Innovations is a software solution that enables the enterprise management of hospitals and independent laboratories.
ROPER TECHNOLOGIES INC
6496 University Parkway
Sarasota FLORIDA 34240 US
CEO: L. Neil Hunn
Employees: 18200
Phone: 19415562601
Roper Technologies, Inc. is a diversified technology company, which engages in the provision of engineered products and solutions for global niche markets. The company is headquartered in Sarasota, Florida and currently employs 18,200 full-time employees. The company operates businesses that design and develop vertical software and technology-enabled products for a variety of defensible niche markets. The firm operates through three segments: Application Software, Network Software and Technology Enabled Products. The Application Software segment includes Aderant, Clinisys, Data Innovations, Deltek, Frontline, IntelliTrans, PowerPlan, Procare, Strata, Transact/CBORD, and Vertafore. The Network Software segment includes ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, and SoftWriters. The Technology Enabled Products segment includes CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS, and Verathon. Aderant is a comprehensive management software solution for law and other professional services firms. Data Innovations is a software solution that enables the enterprise management of hospitals and independent laboratories.
The current stock price of ROP is 445.11 USD. The price increased by 1.24% in the last trading session.
ROPER TECHNOLOGIES INC (ROP) has a dividend yield of 0.83%. The yearly dividend amount is currently 3.01.
ROP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
ROP stock is listed on the Nasdaq exchange.
ROPER TECHNOLOGIES INC (ROP) currently has 18200 employees.
ROPER TECHNOLOGIES INC (ROP) will report earnings on 2026-01-28, after the market close.
ChartMill assigns a fundamental rating of 5 / 10 to ROP. ROP scores excellent on profitability, but there are concerns on its financial health.
Over the last trailing twelve months ROP reported a non-GAAP Earnings per Share(EPS) of 19.6. The EPS increased by 9.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.34% | ||
| ROA | 4.54% | ||
| ROE | 7.85% | ||
| Debt/Equity | 0.46 |
23 analysts have analysed ROP and the average price target is 580.62 USD. This implies a price increase of 30.44% is expected in the next year compared to the current price of 445.11.
For the next year, analysts expect an EPS growth of 9.91% and a revenue growth 13.32% for ROP